Abstract. The 
drastically reduced in these diseases than total IGF. Apparently, only IGF I is under growth hormone control. The liver seems to be involved in the production of IGF.
3) No (Rinderknecht & Humbel 1978a,b) . Their amino acid sequences displaỹ 50% structural homology to the A-and B-chain of human insulin. Their biologic actions comprise insulin-like effects in the presence of excess insulin antibodies on adipose tissue (Zapf et al. 1978a ), heart (Meuli & Froesch 1975 ) and skeletal muscle (Poggi et al. 1979) as well as growth promoting and sulphation activities (Zapf et al. 1978a ). The two polypeptides are closely related to the somatomedins (Zapf et al. 1978a ), a family of polypeptides which are held responsible for mediating the ac¬ tions of growth hormone on some of its target tissues (Daughaday et al. 1972; Chochinov & Daughaday 1976; van Wyk & Underwood 1978) .
When total non-suppressible insulin-like activity in whole serum is measured by the fat pad assayconflicting results are obtained. For instance, activ¬ ities in whole serum of normal subjects, acromegalic and hvpopituitary patients were found to be the same (Schlumpf et al. 1976 ). In contrast, mar¬ ked differences became apparent when sera were gel-filtered at acidic pH and determinations car¬ ried out in the small mol. wt. fractions (Schlumpf et (Meuli et al. 1978; Zapf et al. 1979) , and the in vitro effects of whole serum on adipose tissue appear to be due to large mol. wt. NSILA (Zapfetal. 1979) .
In the present work we have used a one-step Chromatographie procedure (gel filtration on Se¬ phadex G-50 in 1 mol/1 acetic acid) to separate IGF from its carrier Megyesi et al. 1975; Schalch et al. 1979) . IGF was then deter¬ mined in small mol. wt. serum fractions by 4 completely different methods: 2 biological assays (fat pad and fat cell assay) and a competitive protein binding assay , which measure total IGF, and a recently developed radio¬ immunoassay (RIA) ).
Equal aliquots of the 3 pools were re-combined, relyophilized, taken up in Krebs-Ringer bicarbonate buffer containing 2 g/1 of human serum albumin (HSA), and IGF was measured in the fat pad assay (Froesch et al. 1963 ). the fat cell assay and in the IGF I-RIA (see below).
The pools eluting between 30 an 507c bed volume, which contain the large mol. wt. NSILA (Zapf et al. 1978c) ,4C-incorporation into total lipids was determined in 300 u.1 aliquots of the cell suspension centrifuged (10 000 g, 20 s, Beckman microfuge B) through a layer of dinonylphthalate (50 u.1) in 400 u.1 plastic microtubes as described by Gliemann et al. (1975) .
The tops of the microtubes containing the packed cell laver were cut off and counted in 5 ml of Instagel (Packard) (Poffenbarger 1975; Zapf et al. 1978c Furlanetto et al. 1977; Hall et al. 1979) . Thus, besides all the other properties shared with the somatomedins, IGF I resembles the latter also with respect to its GH-dependence.
The finding that total IGF levels are increased in acromegaly, which confirms and extends earlier observations (Schlumpf et al. 1976; Zapf et al. 1977; Heinrich et al. 1978) , is in contrast to the report of Megyesi et al. (1975, 1977) (Rechler et al. 1977 and in press). There¬ fore, Megyesi et al. (1975 Megyesi et al. ( . 1977 (Lewis et al. 1978) . A similar lack of correlation between immunoreactive growth hormone and biologically measured somatomedin activity has al¬ ready been reported by Yde (1969 (Fig. 2) . Hall et al. (1979) (Poffenbarger 1975) , which has been reported to be elevated in tumour hypoglycaemia (Ganda et 
